» Download Public Reports
25 reports
- Company report
- March 2012
- 38 pages
March 2012
... Of an existing or new r&d program in the pipeline. While other companies in the drug delivery market space have obtained such partnerships or grants in the past, there can be no assurance that the company ...
June 2011
... Have positioned ourselves as a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. drug delivery systems are an important ...
March 2012
... First-to-file opportunities o establish manufacturing independence Focus on high technology barrier to entry manufacturing, and Manufacturing of novel drug delivery products; Solid dose ...
April 2013
... Product cands, and the timing and amount of any available investment tax credits, the actual or perceived benefits to users of our drug delivery technologies and product cands as compared ...
December 2012
... Manufacturing and commercialization of unique gelatin-based dosage forms. Banner has developed several patent-pending drug delivery platforms, including those that enhance and control the absorption of poorly ...
November 2012
... delivery system technology. In accordance with the accounting standard for discontinued operations, the results of operations relating to both the visudyne business and the punctal plug drug delivery system ...
March 2011
... powder inhaler to deliver albuterol, a standard treatment in the prevention and treatment of asthma symptoms Anticipated to provide equal efficacy to currently marketed albuterol products ...
May 2012
... Or perceived benefits to users of our drug delivery technologies and product cands as compared to others, our ability to maintain and establish intellectual property rights in our drug delivery ...